{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T15:16:03Z","timestamp":1783091763789,"version":"3.54.6"},"reference-count":71,"publisher":"PeerJ","license":[{"start":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T00:00:00Z","timestamp":1702252800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"crossref","award":["2021JJ30919"],"award-info":[{"award-number":["2021JJ30919"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Changsha Municipal Natural Science Foundation","award":["kq2014252"],"award-info":[{"award-number":["kq2014252"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n               <jats:title>Objective<\/jats:title>\n               <jats:p>To investigate the effect of the kinase inhibitor AT9283 on Burkitt lymphoma (BL) cells and elucidate the underlying mechanisms.<\/jats:p>\n            <\/jats:sec>\n            <jats:sec>\n               <jats:title>Methods<\/jats:title>\n               <jats:p>The effect of AT9283 on the proliferation of BL cell lines was tested using the MTT assay. Apoptosis and cell cycle were measured by flow cytometry. The proteins associated with the cell cycle, apoptosis, and the Warburg effect were detected using Western blotting. Alterations in glycolytic metabolism in terms of glucose intake and lactate concentrations were determined by glucose and lactate assays.<\/jats:p>\n            <\/jats:sec>\n            <jats:sec>\n               <jats:title>Results<\/jats:title>\n               <jats:p>The current study utilized the GEPIA, the Human Protein Atlas (HAP) database and immunohistochemistry to conduct analyses, which revealed a high expression of Aurora kinases and Warburg effect-related proteins in malignant B-cell lymphoma tissues. AT9283 significantly inhibited the cell proliferation of BL cells and induced G2\/M arrest. Additionally, AT9283 induced apoptosis in BL cells and reversed the Warburg effect by increasing glucose uptake and reducing lactate production. Moreover, the protein expression of hexokinase 2, pyruvate kinase M2, and lactate dehydrogenase A was significantly suppressed by AT9283, possibly through the inhibition of c-Myc and HIF-1\u03b1 protein expression.<\/jats:p>\n            <\/jats:sec>\n            <jats:sec>\n               <jats:title>Conclusion<\/jats:title>\n               <jats:p>The reversal of the Warburg effect in BL cells and the subsequent inhibition of cell proliferation and induction of apoptosis were observed by targeting Aurora A and Aurora B with AT9283. This finding may present new therapeutic options and targets for BL.<\/jats:p>\n            <\/jats:sec>","DOI":"10.7717\/peerj.16581","type":"journal-article","created":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T08:50:34Z","timestamp":1702284634000},"page":"e16581","source":"Crossref","is-referenced-by-count":5,"title":["The Aurora kinase inhibitor AT9283 inhibits Burkitt lymphoma growth by regulating Warburg effect"],"prefix":"10.7717","volume":"11","author":[{"given":"Kaiming","family":"Jiang","sequence":"first","affiliation":[{"name":"Department of Hematology, The Second Xiangya Hospital, Central South University, Changsha, Hunan,  China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Bai","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Second Xiangya Hospital, Central South University, Changsha, Hunan,  China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canfei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Second Xiangya Hospital, Central South University, Changsha, Hunan,  China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Second Xiangya Hospital, Central South University, Changsha, Hunan,  China"},{"name":"Institute of Molecular Hematology, Central South University, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Second Xiangya Hospital, Central South University, Changsha, Hunan,  China"},{"name":"Institute of Molecular Hematology, Central South University, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongling","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Second Xiangya Hospital, Central South University, Changsha, Hunan,  China"},{"name":"Institute of Molecular Hematology, Central South University, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sufang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Second Xiangya Hospital, Central South University, Changsha, Hunan,  China"},{"name":"Institute of Molecular Hematology, Central South University, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4443","published-online":{"date-parts":[[2023,12,11]]},"reference":[{"key":"10.7717\/peerj.16581\/ref-1","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/s0962-8924(00)01880-8","article-title":"Chromosomal passengers and the (aurora) ABCs of mitosis","volume":"11","author":"Adams","year":"2001","journal-title":"Trends in Cell Biology"},{"key":"10.7717\/peerj.16581\/ref-2","doi-asserted-by":"publisher","first-page":"56081","DOI":"10.18632\/oncotarget.9760","article-title":"Hexokinase 2 promotes tumor growth and metastasis by regulating lactate production in pancreatic cancer","volume":"8","author":"Anderson","year":"2017","journal-title":"Oncotarget"},{"key":"10.7717\/peerj.16581\/ref-3","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3389\/fonc.2015.00278","article-title":"Aurora kinase inhibitors: current status and outlook","volume":"5","author":"Bavetsias","year":"2015","journal-title":"Frontiers in Oncology"},{"key":"10.7717\/peerj.16581\/ref-4","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1007\/s00018-019-03310-2","article-title":"Insights into the non-mitotic functions of Aurora kinase A: more than just cell division","volume":"77","author":"Bertolin","year":"2020","journal-title":"Cellular and Molecular Life Science"},{"key":"10.7717\/peerj.16581\/ref-5","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1158\/1055-9965.EPI-07-0669","article-title":"AURKA and breast cancer in BRCA1\/2 mutation carriers","volume":"16","author":"Bodvarsdottir","year":"2007","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"key":"10.7717\/peerj.16581\/ref-6","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1158\/2159-8290.CD-12-0345","article-title":"Cancer cell metabolism: one hallmark, many faces","volume":"2","author":"Cantor","year":"2012","journal-title":"Cancer Discovery"},{"key":"10.7717\/peerj.16581\/ref-7","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.bbcan.2012.06.004","article-title":"Dysregulation of glucose transport, glycolysis, TCA cycle and glutaminolysis by oncogenes and tumor suppressors in cancer cells","volume":"1826","author":"Chen","year":"2012","journal-title":"Biochimica et Biophysica Acta\/General Subjects"},{"key":"10.7717\/peerj.16581\/ref-8","doi-asserted-by":"publisher","first-page":"5566","DOI":"10.1038\/s41467-019-13485-8","article-title":"Aurora-A mediated phosphorylation of LDHB promotes glycolysis and tumor progression by relieving the substrate-inhibition effect","volume":"10","author":"Cheng","year":"2019","journal-title":"Nature Communications"},{"key":"10.7717\/peerj.16581\/ref-9","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.4161\/cc.8.12.8741","article-title":"Aurora B kinase inhibition in mitosis: strategies for optimising the use of aurora kinase inhibitors such as AT9283","volume":"8","author":"Curry","year":"2009","journal-title":"Cell Cycle"},{"key":"10.7717\/peerj.16581\/ref-10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nrc2274","article-title":"The interplay between MYC and HIF in cancer","volume":"8","author":"Dang","year":"2008","journal-title":"Nature Reviews Cancer"},{"key":"10.7717\/peerj.16581\/ref-11","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/nm.4107","article-title":"A MYC-aurora kinase A protein complex represents an actionable drug target in p53-altered liver cancer","volume":"22","author":"Dauch","year":"2016","journal-title":"Nature Medicine"},{"key":"10.7717\/peerj.16581\/ref-12","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13045-019-0716-7","article-title":"Molecular pathogenic pathways in extranodal NK\/T cell lymphoma","volume":"12","author":"de\u00a0Mel","year":"2019","journal-title":"Journal of Hematology & Oncology"},{"key":"10.7717\/peerj.16581\/ref-13","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.molcel.2015.11.006","article-title":"Targeting mitosis in cancer: emerging strategies","volume":"60","author":"Dominguez-Brauer","year":"2015","journal-title":"Molecular Cell"},{"key":"10.7717\/peerj.16581\/ref-14","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/s41589-018-0081-9","article-title":"Kinome rewiring reveals AURKA limits PI3K-pathway inhibitor efficacy in breast cancer","volume":"14","author":"Donnella","year":"2018","journal-title":"Nature Chemical Biology"},{"key":"10.7717\/peerj.16581\/ref-15","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/j.hoc.2016.07.009","article-title":"Update on Burkitt Lymphoma","volume":"30","author":"Dunleavy","year":"2016","journal-title":"Hematology\/Oncology Clinics of North America"},{"key":"10.7717\/peerj.16581\/ref-16","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1111\/bjh.15734","article-title":"Mature B-NHL in children, adolescents and young adults: current therapeutic approach and emerging treatment strategies","volume":"185","author":"Egan","year":"2019","journal-title":"British Journal of Haematology"},{"key":"10.7717\/peerj.16581\/ref-17","doi-asserted-by":"publisher","first-page":"5501s","DOI":"10.1158\/1078-0432.CCR-07-0980","article-title":"Cell cycle disturbances and mitotic catastrophes in HeLa Hep2 cells following 2.5 to 10 Gy of ionizing radiation","volume":"13","author":"Eriksson","year":"2007","journal-title":"Clinical Cancer Research"},{"key":"10.7717\/peerj.16581\/ref-18","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1182\/blood.2020006926","article-title":"Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers","volume":"137","author":"Evens","year":"2021","journal-title":"Blood"},{"key":"10.7717\/peerj.16581\/ref-19","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1615\/CritRevImmunol.v32.i4.30","article-title":"The role of the proto-oncogene c-myc in B lymphocyte differentiation","volume":"32","author":"Fernandez","year":"2012","journal-title":"Critical Reviews in Immunology"},{"key":"10.7717\/peerj.16581\/ref-20","doi-asserted-by":"publisher","first-page":"10037","DOI":"10.3390\/ijms231710037","article-title":"Revisited metabolic control and reprogramming cancers by means of the Warburg effect in tumor cells","volume":"23","author":"Fukushi","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"key":"10.7717\/peerj.16581\/ref-21","doi-asserted-by":"publisher","first-page":"742","DOI":"10.14740\/jocmr2295w","article-title":"Aurora kinases and potential medical applications of aurora kinase inhibitors: a review","volume":"7","author":"Gavriilidis","year":"2015","journal-title":"Journal of Clinical Medicine Research"},{"key":"10.7717\/peerj.16581\/ref-22","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/onc.2014.14","article-title":"The aurora kinases in cell cycle and leukemia","volume":"34","author":"Goldenson","year":"2015","journal-title":"Oncogene"},{"key":"10.7717\/peerj.16581\/ref-23","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.7717\/peerj.16581\/ref-24","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.3109\/10428194.2015.1091927","article-title":"A phase II study of AT9283, an aurora kinase inhibitor, in patients with relapsed or refractory multiple myeloma: NCIC clinical trials group IND.191","volume":"57","author":"Hay","year":"2016","journal-title":"Leukemia and Lymphoma"},{"key":"10.7717\/peerj.16581\/ref-25","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1021\/jm800984v","article-title":"Fragment-based discovery of the pyrazol-4-yl urea (AT9283), a multitargeted kinase inhibitor with potent aurora kinase activity","volume":"52","author":"Howard","year":"2009","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.7717\/peerj.16581\/ref-26","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1158\/1535-7163.MCT-07-0067","article-title":"A novel treatment strategy targeting Aurora kinases in acute myelogenous leukemia","volume":"6","author":"Ikezoe","year":"2007","journal-title":"Molecular Cancer Therapeutics"},{"key":"10.7717\/peerj.16581\/ref-27","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.ijrobp.2010.09.012","article-title":"Genetic variants of NPAT-ATM and AURKA are associated with an early adverse reaction in the gastrointestinal tract of patients with cervical cancer treated with pelvic radiation therapy","volume":"81","author":"Ishikawa","year":"2011","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.7717\/peerj.16581\/ref-28","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/ng1279","article-title":"Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53","volume":"36","author":"Katayama","year":"2004","journal-title":"Nature Genetics"},{"key":"10.7717\/peerj.16581\/ref-29","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/nrc1502","article-title":"Aurora-kinase inhibitors as anticancer agents","volume":"4","author":"Keen","year":"2004","journal-title":"Nature Reviews Cancer"},{"key":"10.7717\/peerj.16581\/ref-30","doi-asserted-by":"publisher","first-page":"7381","DOI":"10.1128\/MCB.00440-07","article-title":"Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1","volume":"27","author":"Kim","year":"2007","journal-title":"Molecular and Cellular Biology"},{"key":"10.7717\/peerj.16581\/ref-31","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/371346a0","article-title":"Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE","volume":"371","author":"Lazebnik","year":"1994","journal-title":"Nature"},{"key":"10.7717\/peerj.16581\/ref-32","first-page":"330","article-title":"Burkitt lymphoma","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Leoncini","year":"2017"},{"key":"10.7717\/peerj.16581\/ref-33","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.3390\/molecules21121730","article-title":"The HK2 dependent Warburg effect and mitochondrial oxidative phosphorylation in cancer: targets for effective therapy with 3-Bromopyruvate","volume":"21","author":"Lis","year":"2016","journal-title":"Molecules"},{"key":"10.7717\/peerj.16581\/ref-34","doi-asserted-by":"publisher","first-page":"698023","DOI":"10.3389\/fonc.2021.698023","article-title":"The mechanism of Warburg effect-induced chemoresistance in cancer","volume":"11","author":"Liu","year":"2021","journal-title":"Frontiers in Oncology"},{"key":"10.7717\/peerj.16581\/ref-35","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1093\/carcin\/bgs364","article-title":"(-)-Epigallocatechin-3-gallate inhibition of Epstein-Barr virus spontaneous lytic infection involves ERK1\/2 and PI3-K\/Akt signaling in EBV-positive cells","volume":"34","author":"Liu","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.7717\/peerj.16581\/ref-36","doi-asserted-by":"publisher","first-page":"e14737","DOI":"10.14814\/phy2.14737","article-title":"Burkitt lymphoma and lactic acidosis: a case report and review of the literature","volume":"9","author":"Looyens","year":"2021","journal-title":"Physiological Reports"},{"key":"10.7717\/peerj.16581\/ref-37","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s00109-018-1645-6","article-title":"PKM2-dependent metabolic reprogramming in CD4(+) T cells is crucial for hyperhomocysteinemia-accelerated atherosclerosis","volume":"96","author":"Lu","year":"2018","journal-title":"Journal of Molecular Medicine (Berl)"},{"key":"10.7717\/peerj.16581\/ref-38","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1002\/mc.22223","article-title":"Aurora kinase A mediates c-Myc\u2019s oncogenic effects in hepatocellular carcinoma","volume":"54","author":"Lu","year":"2015","journal-title":"Molecular Carcinogenesis"},{"key":"10.7717\/peerj.16581\/ref-39","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.semcancer.2005.04.009","article-title":"Pyruvate kinase type M2 and its role in tumor growth and spreading","volume":"15","author":"Mazurek","year":"2005","journal-title":"Seminars in Cancer Biology"},{"key":"10.7717\/peerj.16581\/ref-40","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1002\/cncr.32033","article-title":"Targeting Burkitt lymphoma with a tumor cell-specific heptamethine carbocyanine-cisplatin conjugate","volume":"125","author":"Mrdenovic","year":"2019","journal-title":"Cancer"},{"key":"10.7717\/peerj.16581\/ref-41","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1182\/bloodadvances.2019000232","article-title":"The role of aurora A and polo-like kinases in high-risk lymphomas","volume":"3","author":"Murga-Zamalloa","year":"2019","journal-title":"Blood Advances"},{"key":"10.7717\/peerj.16581\/ref-42","doi-asserted-by":"publisher","first-page":"e0136142","DOI":"10.1371\/journal.pone.0136142","article-title":"Different mechanisms of regulation of the Warburg effect in lymphoblastoid and burkitt lymphoma cells","volume":"10","author":"Mushtaq","year":"2015","journal-title":"PLOS ONE"},{"key":"10.7717\/peerj.16581\/ref-43","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.exphem.2019.09.023","article-title":"Glycolytic enzyme hexokinase II is a putative therapeutic target in B-cell malignant lymphoma","volume":"78","author":"Nakajima","year":"2019","journal-title":"Experimental Hematology"},{"key":"10.7717\/peerj.16581\/ref-44","doi-asserted-by":"publisher","first-page":"5203","DOI":"10.1038\/s41467-021-25501-x","article-title":"Aurora kinase A inhibition reverses the Warburg effect and elicits unique metabolic vulnerabilities in glioblastoma","volume":"12","author":"Nguyen","year":"2021","journal-title":"Nature Communications"},{"key":"10.7717\/peerj.16581\/ref-45","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1200\/JCO.18.00899","article-title":"Randomized phase III study of Alisertib or investigator\u2019s choice (selected single agent) in patients with relapsed or refractory peripheral T-cell lymphoma","volume":"37","author":"O\u2019Connor","year":"2019","journal-title":"Journal of Clinical Oncology"},{"key":"10.7717\/peerj.16581\/ref-46","doi-asserted-by":"publisher","first-page":"33533","DOI":"10.1074\/jbc.273.50.33533","article-title":"Importance of poly(ADP-ribose) polymerase and its cleavage in apoptosis. Lesson from an uncleavable mutant","volume":"273","author":"Oliver","year":"1998","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"10.7717\/peerj.16581\/ref-47","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1182\/asheducation-2008.1.341","article-title":"Burkitt lymphoma in adults","volume":"2008","author":"Perkins","year":"2008","journal-title":"Hematology\/the Education Program of the American Society of Hematology"},{"key":"10.7717\/peerj.16581\/ref-48","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.1002\/ijc.26324","article-title":"AT9283, a novel aurora kinase inhibitor, suppresses tumor growth in aggressive B-cell lymphomas","volume":"130","author":"Qi","year":"2012","journal-title":"International Journal of Cancer"},{"key":"10.7717\/peerj.16581\/ref-49","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.leukres.2016.06.011","article-title":"Reversine triggers mitotic catastrophe and apoptosis in K562 cells","volume":"48","author":"Rodrigues\u00a0Alves","year":"2016","journal-title":"Leukemia Research"},{"key":"10.7717\/peerj.16581\/ref-50","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1056\/NEJMra2025746","article-title":"Burkitt\u2019s Lymphoma","volume":"387","author":"Roschewski","year":"2022","journal-title":"New England Journal of Medicine"},{"key":"10.7717\/peerj.16581\/ref-51","doi-asserted-by":"publisher","first-page":"e26557","DOI":"10.7759\/cureus.26557","article-title":"An oncological emergency: severe type B lactic acidosis from Warburg effect in diffuse large B-cell lymphoma","volume":"14","author":"Sanivarapu","year":"2022","journal-title":"Cureus"},{"key":"10.7717\/peerj.16581\/ref-52","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.1158\/1078-0432.CCR-10-3012","article-title":"Antimyeloma activity of a multitargeted kinase inhibitor, AT9283, via potent Aurora kinase and STAT3 inhibition either alone or in combination with lenalidomide","volume":"17","author":"Santo","year":"2011","journal-title":"Clinical Cancer Research"},{"key":"10.7717\/peerj.16581\/ref-53","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/356356a0","article-title":"Role of poly(ADP-ribose) formation in DNA repair","volume":"356","author":"Satoh","year":"1992","journal-title":"Nature"},{"key":"10.7717\/peerj.16581\/ref-54","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12943-015-0321-5","article-title":"Apoptosis, autophagy, necroptosis, and cancer metastasis","volume":"14","author":"Su","year":"2015","journal-title":"Molecular Cancer"},{"key":"10.7717\/peerj.16581\/ref-55","doi-asserted-by":"publisher","first-page":"6928","DOI":"10.7150\/thno.43811","article-title":"Aurora-A\/SOX8\/FOXK1 signaling axis promotes chemoresistance via suppression of cell senescence and induction of glucose metabolism in ovarian cancer organoids and cells","volume":"10","author":"Sun","year":"2020","journal-title":"Theranostics"},{"key":"10.7717\/peerj.16581\/ref-56","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.3892\/or.2020.7739","article-title":"AT9283 exhibits antiproliferative effect on tyrosine kinase inhibitor-sensitive and -resistant chronic myeloid leukemia cells by inhibition of Aurora A and Aurora B","volume":"44","author":"Takeda","year":"2020","journal-title":"Oncology Reports"},{"key":"10.7717\/peerj.16581\/ref-57","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1182\/blood-2009-03-211466","article-title":"Activity of the multitargeted kinase inhibitor, AT9283, in imatinib-resistant BCR-ABL-positive leukemic cells","volume":"116","author":"Tanaka","year":"2010","journal-title":"Blood"},{"key":"10.7717\/peerj.16581\/ref-58","doi-asserted-by":"publisher","first-page":"23937","DOI":"10.18632\/oncotarget.14893","article-title":"Aurora kinases: novel therapy targets in cancers","volume":"8","author":"Tang","year":"2017","journal-title":"Oncotarget"},{"key":"10.7717\/peerj.16581\/ref-59","doi-asserted-by":"publisher","first-page":"W556","DOI":"10.1093\/nar\/gkz430","article-title":"GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis","volume":"47","author":"Tang","year":"2019","journal-title":"Nucleic Acids Research"},{"key":"10.7717\/peerj.16581\/ref-60","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses","volume":"45","author":"Tang","year":"2017","journal-title":"Nucleic Acids Research"},{"key":"10.7717\/peerj.16581\/ref-61","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.3390\/biom10101365","article-title":"High NRF2 levels correlate with poor prognosis in colorectal cancer patients and with sensitivity to the kinase inhibitor AT9283 In Vitro","volume":"10","author":"Torrente","year":"2020","journal-title":"Biomolecules"},{"key":"10.7717\/peerj.16581\/ref-62","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ebiom.2017.10.026","article-title":"Solid cancer treatment with aurora kinase inhibitors: towards a personalized medicine","volume":"25","author":"Ulisse","year":"2017","journal-title":"EBioMedicine"},{"key":"10.7717\/peerj.16581\/ref-63","doi-asserted-by":"publisher","first-page":"e26351","DOI":"10.1002\/pbc.26351","article-title":"A phase I\/II trial of AT9283, a selective inhibitor of aurora kinase in children with relapsed or refractory acute leukemia: challenges to run early phase clinical trials for children with leukemia","volume":"64","author":"Vormoor","year":"2017","journal-title":"Pediatric Blood & Cancer"},{"key":"10.7717\/peerj.16581\/ref-64","doi-asserted-by":"publisher","first-page":"8358","DOI":"10.1002\/jcp.29680","article-title":"Aurora kinase inhibitor restrains STAT5-activated leukemic cell proliferation by inducing mitochondrial impairment","volume":"235","author":"Wang","year":"2020","journal-title":"Journal of Cellular Physiology"},{"key":"10.7717\/peerj.16581\/ref-65","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.21037\/jgo-22-389","article-title":"c-MYC and HIF1alpha promoter G-quadruplexes dependent metabolic regulation mechanism of berberine in colon cancer","volume":"13","author":"Wen","year":"2022","journal-title":"Journal of Gastrointestinal Oncology"},{"key":"10.7717\/peerj.16581\/ref-66","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1242\/jeb.00241","article-title":"Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function","volume":"206","author":"Wilson","year":"2003","journal-title":"Journal of Experimental Biology"},{"key":"10.7717\/peerj.16581\/ref-67","doi-asserted-by":"publisher","first-page":"32332","DOI":"10.18632\/oncotarget.15974","article-title":"Poor prognosis of hexokinase 2 overexpression in solid tumors of digestive system: a meta-analysis","volume":"8","author":"Wu","year":"2017","journal-title":"Oncotarget"},{"key":"10.7717\/peerj.16581\/ref-68","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/1440-1681.13037","article-title":"(-)-Epigallocatechin-3-gallate induces cell apoptosis in chronic myeloid leukaemia by regulating Bcr\/Abl-mediated p38-MAPK\/JNK and JAK2\/STAT3\/AKT signalling pathways","volume":"46","author":"Xiao","year":"2019","journal-title":"Clinical and Experimental Pharmacology and Physiology"},{"key":"10.7717\/peerj.16581\/ref-69","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1002\/med.21399","article-title":"Aurora-A kinase: a potent oncogene and target for cancer therapy","volume":"36","author":"Yan","year":"2016","journal-title":"Medicinal Research Reviews"},{"key":"10.7717\/peerj.16581\/ref-70","doi-asserted-by":"publisher","first-page":"759","DOI":"10.3858\/emm.2010.42.11.077","article-title":"Suppression of Aurora-A oncogenic potential by c-Myc downregulation","volume":"42","author":"Yang","year":"2010","journal-title":"Experimental & Molecular Medicine"},{"key":"10.7717\/peerj.16581\/ref-71","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41420-021-00655-1","article-title":"The JAK2 inhibitor TG101209 exhibits anti-tumor and chemotherapeutic sensitizing effects on Burkitt lymphoma cells by inhibiting the JAK2\/STAT3\/c-MYB signaling axis","volume":"7","author":"Zhang","year":"2021","journal-title":"Cell Death Discovery"}],"container-title":["PeerJ"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/peerj.com\/articles\/16581.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/16581.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/16581.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/16581.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T08:50:57Z","timestamp":1702284657000},"score":1,"resource":{"primary":{"URL":"https:\/\/peerj.com\/articles\/16581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,11]]},"references-count":71,"alternative-id":["10.7717\/peerj.16581"],"URL":"https:\/\/doi.org\/10.7717\/peerj.16581","archive":["CLOCKSS","LOCKSS","Portico"],"relation":{},"ISSN":["2167-8359"],"issn-type":[{"value":"2167-8359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,11]]},"article-number":"e16581"}}